ヒドロキシジン市場- 世界の産業規模、シェア、動向、機会、予測、剤形別、適応症タイプ別、地域別、競合、2019年～2029年

ヒドロキシジンの世界市場規模は2023年に5億209万米ドルとなり、2029年までのCAGRは6.12%で、予測期間中に目覚ましい成長を遂げると予測されています。

ヒドロキシジンの世界市場は、様々な医療領域におけるヒドロキシジンアプリケーションの拡大により、顕著な成長を遂げています。第一世代の抗ヒスタミン薬であるヒドロキシジンは、アレルギー、不安、特定の皮膚疾患の症状を緩和するために広く使用されています。抗ヒスタミン作用と抗不安作用があるため、汎用性の高い薬です。アレルギー反応や不安障害の有病率の増加とヒドロキシジンの効能に対する認識の高まりが、市場の上昇に寄与しています。アレルギー管理の領域では、ヒドロキシジンはアレルギー反応に伴うかゆみ、じんましん、鼻炎などの症状を緩和する上で重要な役割を果たしています。環境汚染やライフスタイルの変化によるアレルギーの増加は、ヒドロキシジンの重要性を強調しています。ヒドロキシジンは抗ヒスタミン作用だけでなく、抗不安作用も認められており、不安障害の管理にも役立っています。ヒドロキシジンの鎮静作用は、不安症の短期治療薬として使用され、他の抗不安薬に代わる依存性のない治療薬として貢献しています。ヒドロキシジンの潜在的な用途に対する理解が深まり、市場はさらに拡大しています。新たな治療法の研究が進むにつれて、ヒドロキシジンの役割は、皮膚掻痒症や特定の皮膚疾患の管理に有望視されている皮膚科などの分野にも拡大する可能性があります。ヒドロキシジンの持続的な需要には、アレルギー疾患や不安障害に罹患しやすい老年人口の増加などの要因が寄与しています。また、比較的良好な安全性プロファイルと費用対効果により、さまざまなヘルスケア場面でその魅力をさらに高めています。製薬会社が製品ポートフォリオの拡大と製剤の最適化に注力していることから、ヒドロキシジンの世界市場は継続的な成長が見込まれています。ヒドロキシジンの多用途性は、その確立された安全性プロファイルと相まって、様々な病状に対処するための貴重な資産として位置付けられ、世界の医薬品状況におけるその継続的な関連性を確実なものにしています。

市場促進要因

アレルギーの増加

不安障害の増加

主な市場課題

ジェネリック医薬品の競合

重篤な不安症例における限定的な有効性

主要市場動向

メンタルヘルス治療薬に対する需要の高まり

新規製剤の継続的調査

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のヒドロキシジン市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 剤形別（錠剤、カプセル剤、注射剤、シロップ剤）
  • 適応症別（ヒスタミン性掻痒症、蕁麻疹、アトピー性接触皮膚炎）
  • 地域別
  • 企業別（2023）
• 市場マップ
  • 剤形別
  • 適応症タイプ別
  • 地域別

第6章 アジア太平洋地域のヒドロキシジン市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 剤形別
  • 適応症タイプ別
  • 国別
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第7章 欧州のヒドロキシジン市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 剤形別
  • 適応症タイプ別
  • 国別
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第8章 北米のヒドロキシジン市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 剤形別
  • 適応症タイプ別
  • 国別
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第9章 南米のヒドロキシジン市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 剤形別
  • 適応症タイプ別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのヒドロキシジン市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 剤形別
  • 適応症タイプ別
  • 国別
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • エジプト

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 世界のヒドロキシジン市場：SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• R-Biopharm AG
• Teva Pharmaceutical Industries Ltd
• Sun Pharmaceutical Industries Ltd
• GSK plc
• bioMerieux S.A.
• Danaher Corporation
• Thermo Fisher Scientific, Inc
• Siemens Healthcare AG
• AbbVie Inc.
• Pfizer Inc.

第16章 戦略的提言

第17章 調査会社について・免責事項

Global Hydroxyzine Market was valued at USD 502.09 million in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.12% through 2029. The Global Hydroxyzine Market is experiencing notable growth, driven by the expanding application of hydroxyzine across various medical domains. Hydroxyzine, a first-generation antihistamine, is widely used to alleviate symptoms of allergies, anxiety, and certain skin conditions. Its antihistaminic and anxiolytic properties make it a versatile medication. The increasing prevalence of allergic reactions and anxiety disorders, coupled with the growing awareness of hydroxyzine's efficacy, contributes to the market's ascent. In the realm of allergy management, hydroxyzine plays a crucial role in mitigating symptoms such as itching, hives, and rhinitis associated with allergic reactions. The rising incidence of allergies, triggered by factors like environmental pollutants and changing lifestyles, underscores the significance of hydroxyzine in providing relief. Beyond its antihistaminic effects, hydroxyzine is recognized for its anxiolytic properties, making it valuable in the management of anxiety disorders. The sedative effects of hydroxyzine contribute to its use as a short-term treatment for anxiety, offering a non-addictive alternative to other anxiolytic medications. The market is witnessing further expansion due to the increased understanding of hydroxyzine's potential applications. As research continues to explore new therapeutic avenues, hydroxyzine's role may extend to areas such as dermatology, where it has shown promise in managing pruritus and certain skin conditions. Factors such as the growing geriatric population, which is more susceptible to allergic conditions and anxiety disorders, contribute to the sustained demand for hydroxyzine. The drug's relatively favorable safety profile and cost-effectiveness further enhance its attractiveness in various healthcare settings. As pharmaceutical companies focus on expanding their product portfolios and optimizing formulations, the Global Hydroxyzine Market is poised for continued growth. The versatility of hydroxyzine, coupled with its well-established safety profile, positions it as a valuable asset in addressing a spectrum of medical conditions, ensuring its continued relevance in the global pharmaceutical landscape.

Key Market Drivers

Increasing Prevalence of Allergies

The Global Hydroxyzine Market is experiencing a notable upswing due to the increasing prevalence of allergies worldwide. Allergic reactions have become more prevalent, with factors such as environmental pollutants, changing dietary habits, and heightened exposure to allergens contributing to a surge in allergy cases. Hydroxyzine, as a first-generation antihistamine, plays a pivotal role in managing allergic conditions. Its ability to alleviate symptoms like itching, hives, and rhinitis associated with allergies positions it as a valuable medication in the treatment arsenal. The heightened awareness of allergic conditions and the need for effective management have led to a growing demand for antihistamines like hydroxyzine. Allergies can manifest in various forms, ranging from mild discomfort to severe and potentially life-threatening reactions. As individuals seek relief from these symptoms, hydroxyzine's antihistaminic properties become increasingly relevant. The rise in allergic conditions across diverse age groups, coupled with the versatile applicability of hydroxyzine in addressing different manifestations of allergies, has contributed to its widespread usage. Pharmaceutical companies are recognizing the market potential and are actively expanding their hydroxyzine-based product offerings to cater to the escalating demand driven by the increasing prevalence of allergies. The Global Hydroxyzine Market is positioned as a key player in the healthcare landscape, providing effective solutions to individuals grappling with the challenges posed by a rising tide of allergic reactions.

Growing Cases of Anxiety Disorders

The Global Hydroxyzine Market is witnessing substantial growth, propelled by the escalating number of anxiety disorders across the globe. Anxiety disorders have become increasingly prevalent due to factors such as heightened stress levels, lifestyle changes, and a growing awareness of mental health issues. Hydroxyzine, with its anxiolytic properties, has emerged as a significant therapeutic option in the management of anxiety-related conditions. As the world grapples with increased stressors and challenges, the demand for effective anxiety treatments has surged. Hydroxyzine, known for its ability to induce sedation and alleviate symptoms of anxiety, offers a non-addictive alternative to other anxiolytic medications. The drug's efficacy in providing short-term relief for anxiety disorders contributes to its widespread use in clinical practice. The pharmaceutical industry recognizes the expanding market for anxiety-related treatments, leading to increased research and development efforts to optimize hydroxyzine formulations. Its non-addictive nature and favorable safety profile make it a preferred choice for healthcare providers seeking reliable solutions for anxiety management. The growing societal acknowledgment of mental health issues and the importance of seeking treatment for anxiety disorders further propels the utilization of hydroxyzine. As a result, the Global Hydroxyzine Market is positioned as a key player in addressing the global mental health landscape, providing patients and healthcare professionals with a valuable tool to manage the challenges posed by the rising cases of anxiety disorders.

Key Market Challenges

Generic Competition

Generic competition poses a significant challenge to the Global Hydroxyzine Market. As hydroxyzine has been in use for several decades and is a well-established medication, the market has witnessed an influx of generic alternatives. The availability of generic versions has led to increased competition among pharmaceutical manufacturers, resulting in price erosion and a potential decline in the market share of branded hydroxyzine products. Generic versions of hydroxyzine are often more cost-effective, making them an attractive option for healthcare providers and payers. The cost savings associated with generic hydroxyzine can lead to a shift in prescribing patterns, impacting the revenue streams of brand-name hydroxyzine products. This competitive environment challenges pharmaceutical companies that initially held patents on branded hydroxyzine formulations. Patients and healthcare systems are often inclined towards more affordable generic medications, given their equivalent efficacy and safety profiles. The widespread adoption of generic hydroxyzine can result in reduced profitability for brand-name products, prompting pharmaceutical companies to explore strategies to differentiate their offerings and maintain a competitive edge. Navigating the landscape of generic competition requires innovative marketing approaches, potentially incorporating additional features or formulations that provide unique value. The companies in the Global Hydroxyzine Market must focus on building brand loyalty among healthcare professionals and patients, emphasizing factors such as consistent quality, reliability, and patient adherence to maintain a resilient market presence amid the challenges posed by generic alternatives.

Limited Efficacy in Severe Anxiety Cases

The Global Hydroxyzine Market encounters a challenge related to the limited efficacy of hydroxyzine in severe anxiety cases. While hydroxyzine is widely acknowledged for its anxiolytic properties, its effectiveness may be constrained when dealing with more severe forms of anxiety disorders. In cases of intense anxiety, where symptoms are profound and debilitating, patients may require more potent anxiolytic medications to achieve adequate relief. Hydroxyzine's mechanism of action as a first-generation antihistamine with sedative effects may not be as robust in addressing the heightened anxiety levels experienced by individuals with severe anxiety disorders. The sedative properties, while beneficial for calming milder forms of anxiety, might not provide sufficient relief for individuals facing acute or chronic severe anxiety. Healthcare professionals may need to explore alternative medications with stronger anxiolytic effects for patients with severe anxiety. This challenge in addressing the spectrum of anxiety severity could impact the market's reach, as hydroxyzine may be perceived as more suitable for mild to moderate anxiety cases. Pharmaceutical companies and healthcare providers need to carefully consider the appropriate use of hydroxyzine in the context of anxiety management, ensuring that patients with varying degrees of severity receive tailored treatments. Addressing the limitations in efficacy for severe anxiety cases may involve a combination of therapeutic approaches and a nuanced understanding of the diverse spectrum of anxiety disorders to optimize patient outcomes in the Global Hydroxyzine Market.

Key Market Trends

Rising Demand for Mental Health Medications

The Global Hydroxyzine Market is experiencing a notable surge in demand, attributed in part to the rising global demand for mental health medications. As awareness of mental health issues grows and societal attitudes toward mental well-being evolve, there is an increased recognition of the prevalence of anxiety-related conditions. Hydroxyzine, with its anxiolytic properties, emerges as a valuable therapeutic option to address the growing demand for effective mental health treatments. The rising prevalence of anxiety disorders, coupled with a broader acknowledgment of the impact of stress and anxiety on overall health, has led to an elevated need for medications that provide relief without fostering dependence. Hydroxyzine's non-addictive nature positions it as an attractive choice in the context of the expanding mental health medication landscape. The demand for mental health medications, including anxiolytics like hydroxyzine, is further fueled by factors such as changing lifestyles, increased stressors, and the global impact of events affecting mental well-being. The trend towards open discussions about mental health and reducing the stigma associated with seeking treatment contributes to a growing willingness among individuals to explore pharmacological interventions for anxiety. Pharmaceutical companies operating in the Global Hydroxyzine Market are likely to witness sustained demand as they address the imperative need for effective and well-tolerated mental health medications. This trend underscores the pivotal role hydroxyzine plays in meeting the evolving healthcare needs related to mental well-being on a global scale.

Ongoing Research for Novel Formulations

The Global Hydroxyzine Market is witnessing a surge in research and development activities focused on creating novel formulations of hydroxyzine. Pharmaceutical companies are actively engaged in ongoing research to enhance the drug's therapeutic efficacy, patient compliance, and overall market appeal. These efforts aim to address various challenges and optimize the clinical utility of hydroxyzine in diverse therapeutic contexts. One area of exploration involves the development of sustained-release formulations. Creating formulations with prolonged release characteristics could potentially provide a more consistent and extended therapeutic effect, reducing the frequency of administration and improving patient adherence to treatment regimens. Combination therapies are also under consideration in research initiatives. By combining hydroxyzine with other complementary compounds, researchers aim to enhance its anxiolytic properties, broaden its spectrum of efficacy, or minimize potential side effects. These novel combinations could offer innovative treatment options for healthcare providers and more tailored solutions for patients. The research is delving into optimizing the bioavailability and pharmacokinetics of hydroxyzine to improve its overall performance. Innovations in drug delivery systems, such as nanoparticles or liposomal formulations, are being explored to enhance the drug's delivery to target tissues and organs, potentially maximizing therapeutic outcomes. The ongoing research for novel formulations reflects the commitment of pharmaceutical researchers to address existing limitations and unlock new therapeutic potentials for hydroxyzine. These endeavors contribute to the dynamic evolution of the Global Hydroxyzine Market, paving the way for innovative products that cater to the evolving healthcare landscape and the diverse needs of patients.

Segmental Insights

Dosage Form Insights

1. Based on dosage form, tablets segment dominated the Global Hydroxyzine Market in 2023. This is ascribed due to its convenience, ease of administration, and dosage accuracy. Hydroxyzine, commonly prescribed for anxiety and allergic conditions, is widely formulated as oral tablets. Tablets offer a standardized dosage, simplifying medication management for both patients and healthcare providers. The solid dosage form ensures stability, easy storage, and a longer shelf life. The patient preference for tablets, coupled with pharmaceutical manufacturers' focus on tablet formulations, contributes to the dominance of this segment in the market, meeting the demand for a widely accepted and practical delivery method for hydroxyzine.

Regional Insights

North America dominated in the Global Hydroxyzine Market, driven by the region benefits from a well-established healthcare infrastructure and a high prevalence of conditions like anxiety and allergies, for which Hydroxyzine is commonly prescribed. North America is home to major pharmaceutical companies with a strong focus on research and development, contributing to the innovation and availability of Hydroxyzine products. Rigorous regulatory standards ensure the safety and efficacy of pharmaceuticals, boosting consumer confidence. A a robust healthcare system and high healthcare expenditure enhance accessibility to Hydroxyzine medications. These factors collectively position North America as the dominant market for Hydroxyzine on the global stage.

Recent Development

In December 2022, Brillpharma (Ireland) received marketing authorization from HPRA for their Hydroxyzine hydrochloride 25mg film-coated tablets. This approval signifies the regulatory endorsement of Brillpharma's product, indicating compliance with standards set by the Health Products Regulatory Authority. The granted authorization enhances Brillpharma's ability to bring this specific formulation of hydroxyzine to the market, contributing to pharmaceutical options available for various therapeutic applications.

Key Market Players

R-Biopharm AG

Teva Pharmaceutical Industries Ltd

Sun Pharmaceutical Industries Ltd

GSK plc

bioMerieux S.A.

Danaher Corporation

Thermo Fisher Scientific, Inc

Siemens Healthcare AG

AbbVie Inc.

Pfizer Inc.

Report Scope:

In this report, the Global Hydroxyzine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Hydroxyzine Market, By Dosage Form:

Tablets Capsules Injection Syrup

Hydroxyzine Market, By Indication Type:

Histamine-mediated pruritus Utricaria Atopic contact dermatitis

Hydroxyzine Market, By Region:

North America
• United States
• Canada
• Mexico
Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
South America
• Brazil
• Argentina
• Colombia
Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Hydroxyzine Market.

Available Customizations:

Global Hydroxyzine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Hydroxyzine Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Dosage Form (Tablets, Capsules, Injection, Syrup)
  • 5.2.2. By Indication Type (Histamine-mediated pruritus, Utricaria, Atopic contact dermatitis)
  • 5.2.3. By Region
  • 5.2.4. By Company (2023)
• 5.3. Market Map
  • 5.3.1. By Dosage Form
  • 5.3.2. By Indication Type
  • 5.3.3. By Region

6. Asia Pacific Hydroxyzine Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Dosage Form
  • 6.2.2. By Indication Type
  • 6.2.3. By Country
• 6.3. Asia Pacific: Country Analysis
  • 6.3.1. China Hydroxyzine Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Dosage Form
      • 6.3.1.2.2. By Indication Type
  • 6.3.2. India Hydroxyzine Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Dosage Form
      • 6.3.2.2.2. By Indication Type
  • 6.3.3. Australia Hydroxyzine Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Dosage Form
      • 6.3.3.2.2. By Indication Type
  • 6.3.4. Japan Hydroxyzine Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Dosage Form
      • 6.3.4.2.2. By Indication Type
  • 6.3.5. South Korea Hydroxyzine Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Dosage Form
      • 6.3.5.2.2. By Indication Type

7. Europe Hydroxyzine Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Dosage Form
  • 7.2.2. By Indication Type
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Hydroxyzine Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Dosage Form
      • 7.3.1.2.2. By Indication Type
  • 7.3.2. Germany Hydroxyzine Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Dosage Form
      • 7.3.2.2.2. By Indication Type
  • 7.3.3. Spain Hydroxyzine Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Dosage Form
      • 7.3.3.2.2. By Indication Type
  • 7.3.4. Italy Hydroxyzine Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Dosage Form
      • 7.3.4.2.2. By Indication Type
  • 7.3.5. United Kingdom Hydroxyzine Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Dosage Form
      • 7.3.5.2.2. By Indication Type

8. North America Hydroxyzine Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Dosage Form
  • 8.2.2. By Indication Type
  • 8.2.3. By Country
• 8.3. North America: Country Analysis
  • 8.3.1. United States Hydroxyzine Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Dosage Form
      • 8.3.1.2.2. By Indication Type
  • 8.3.2. Mexico Hydroxyzine Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Dosage Form
      • 8.3.2.2.2. By Indication Type
  • 8.3.3. Canada Hydroxyzine Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Dosage Form
      • 8.3.3.2.2. By Indication Type

9. South America Hydroxyzine Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Dosage Form
  • 9.2.2. By Indication Type
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Hydroxyzine Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Dosage Form
      • 9.3.1.2.2. By Indication Type
  • 9.3.2. Argentina Hydroxyzine Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Dosage Form
      • 9.3.2.2.2. By Indication Type
  • 9.3.3. Colombia Hydroxyzine Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Dosage Form
      • 9.3.3.2.2. By Indication Type

10. Middle East and Africa Hydroxyzine Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Dosage Form
  • 10.2.2. By Indication Type
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Hydroxyzine Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Dosage Form
      • 10.3.1.2.2. By Indication Type
  • 10.3.2. Saudi Arabia Hydroxyzine Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Dosage Form
      • 10.3.2.2.2. By Indication Type
  • 10.3.3. UAE Hydroxyzine Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Dosage Form
      • 10.3.3.2.2. By Indication Type
  • 10.3.4. Egypt Hydroxyzine Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Dosage Form
      • 10.3.4.2.2. By Indication Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Hydroxyzine Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. Competitive Landscape

• 15.1. R-Biopharm AG
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (In case of listed)
  • 15.1.5. Recent Developments
  • 15.1.6. SWOT Analysis
• 15.2. Teva Pharmaceutical Industries Ltd
• 15.3. Sun Pharmaceutical Industries Ltd
• 15.4. GSK plc
• 15.5. bioMerieux S.A.
• 15.6. Danaher Corporation
• 15.7. Thermo Fisher Scientific, Inc
• 15.8. Siemens Healthcare AG
• 15.9. AbbVie Inc.
• 15.10. Pfizer Inc.

16. Strategic Recommendations

17. About Us & Disclaimer